Dhampur Bio Organics Limited share price
Dhampur Bio Organics Limited, together with its subsidiaries, manufactures and sells sugar in India and internationally. The company operates through three segments: Sugar; Biofuels and Spirits; and Country Liquor. It offers sulphurless sugar and sugar byproducts under the Dhampure brand name; ethanol and biogenic carbon dioxide; spirit and liquor; extra neutral alcohol; bagasse; and organic fertilizer. The company also engages in the cogeneration and sale of power. It exports its products. The company was incorporated in 2020 and is based in New Delhi, India.Read more
Consumer DefensiveFarm ProductsNSE: DBOLISIN INE0I3401014
16 Oct 2026, 3:29 PM IST₹140.73▼ 3.31 (2.30%)
- Market Cap₹ 926 Cr.
- Current Price₹ 140.73
- High / Low₹ 152 / 69
- Stock P/E28.0
- Book Value₹ 155
- Dividend Yield1.04 %
- ROCE7.7 %
- ROE2.50 %
- Face Value₹ 10.0
More figures (10)
- EPS (TTM)₹ 5.03
- Price / Book0.91
- OPM3.9 %
- Debt / Equity1.03
- Sales growth (3Y)5.7 %
- Profit growth (3Y)-39.0 %
- Promoter holding70.1 %
- EV / EBITDA14.9
- Beta0.55
- All-time high₹ 229
Price chart
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| DBOL | +24.09% | +29.91% | +23.22% | +77.76% | +79.14% | -4.01% | — |
| Nifty 50 | -0.31% | -3.85% | -4.34% | -11.42% | -9.53% | +5.46% | +4.76% |
Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.
Quick take
- Dhampur Bio Organics Limited is in the Farm Products industry (Consumer Defensive), with a market value of ₹926 crore.
- It trades at 28.0 times its last 12 months' earnings and 0.9 times book value.
- Revenue grew 5.7% a year over the last 3 years, profit -39.0% a year.
- Return on equity was 2.5% and return on capital employed 7.7% in the latest year.
- Debt was 1.03 times shareholders' equity.
- The share price is 7.3% below its 52-week high and up 79.1% over one year.
- Promoters and insiders hold about 70.1%; institutions about 0.0%.
Pros
AI- Trades at 28.0 times earnings, below its 3-year median of 191.8.
Cons
AI- Return on equity has been low: 2.9% on average over the last 3 years.
- Interest cover is thin: operating earnings are 2.0 times the interest cost.
- Sales growth has been slow: 5.7% a year over the last 3 years.
- Profit growth has been weak: -39.0% a year over the last 3 years.
- Other income makes up 57% of profit before tax.
Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.
AI analysis
Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.
About Dhampur Bio Organics Limited
Dhampur Bio Organics Limited, together with its subsidiaries, manufactures and sells sugar in India and internationally. The company operates through three segments: Sugar; Biofuels and Spirits; and Country Liquor. It offers sulphurless sugar and sugar byproducts under the Dhampure brand name; ethanol and biogenic carbon dioxide; spirit and liquor; extra neutral alcohol; bagasse; and organic fertilizer. The company also engages in the cogeneration and sale of power. It exports its products. The company was incorporated in 2020 and is based in New Delhi, India.
- Employees
- 1,692
- Head office
- New Delhi
Quarterly Results
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Source: the company's results filed with NSE, as reported. EPS restated for bonus issues and splits. Tap a row marked + for its breakdown. Latest quarter on the right.
Profit & Loss
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Projection — your assumptions
Starts from the last four reported quarters (TTM) and applies the figures you enter; growth is pre-filled with the company's own 3-year sales growth. This is a what-if calculator for illustration, not a forecast, estimate or recommendation.
Related party transactions
Related-party transactions are dealings with promoters, directors, subsidiaries and associates. Companies disclose them to the exchanges every half-year and in detail in the notes to their annual report.
- Related Party TransactionsDhampur Bio Organics Limited has informed the Exchange about related Party Transactions09-Oct-2023
- Related Party TransactionsDhampur Bio Organics Limited has informed the Exchange about related Party Transactions26-Apr-2023
- Related Party TransactionDhampur Bio Organics Limited has informed the Exchange about related party transaction for the period ended September 202202-Nov-2022
Full details: notes to the Financial Year 2026 annual report (related party disclosures).
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| 2,654 | 2,394 | 2,693 | 3,133 | 3,268 | |
| YOY Sales Growth % | -9.80% | 12.47% | 16.35% | ||
| 2,450 | 2,258 | 2,558 | 3,003 | 3,130 | |
| Material Cost % | 69% | 57% | 51% | 51% | 48% |
| Employee Cost % | 4% | 4% | 4% | 4% | 3% |
| Other Expenses % | 19% | 33% | 40% | 41% | 44% |
| Operating Profit | 205 | 136 | 135 | 131 | 138 |
| OPM % | 8% | 6% | 5% | 4% | 4% |
| 11 | 24 | 4 | 32 | 31 | |
| Exceptional items | -2 | ||||
| Interest | 41 | 45 | 67 | 63 | 57 |
| Depreciation | 41 | 49 | 54 | 59 | 57 |
| Profit before tax | 135 | 65 | 16 | 41 | 56 |
| 18% | 29% | 6% | 38% | 40% | |
| Current tax | 22 | 11 | 4 | 6 | |
| Deferred tax | 1 | 8 | -3 | 9 | |
| 111 | 46 | 15 | 25 | 84 | |
| Profit to shareholders | 111 | 46 | 17 | 25 | 84 |
| YOY Profit Growth % | -58.15% | -68.40% | 71.41% | ||
| EPS in Rs | 1.67 | 0.70 | 0.22 | 3.81 | 12.75 |
| Dividend Payout % | 50% | 100% | 33% |
Compounded Sales Growth
- 3 Years:
- 6%
- TTM:
- 15%
Compounded Profit Growth
- 3 Years:
- -39%
Stock Price CAGR
- 3 Years:
- -4%
- 1 Year:
- 79%
Return on Equity
- 4 Years:
- 5%
- Last Year:
- 3%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| 2,649 | 2,361 | 2,714 | 3,106 | 3,225 | |
| YOY Sales Growth % | -10.85% | 14.96% | 14.43% | ||
| 2,445 | 2,223 | 2,574 | 2,975 | 3,087 | |
| Material Cost % | 69% | 57% | 52% | 51% | 48% |
| Employee Cost % | 4% | 4% | 4% | 4% | 3% |
| Other Expenses % | 19% | 33% | 39% | 41% | 44% |
| Operating Profit | 203 | 138 | 140 | 131 | 138 |
| OPM % | 8% | 6% | 5% | 4% | 4% |
| 10 | 24 | 4 | 31 | 30 | |
| Exceptional items | 4 | -5 | |||
| Interest | 41 | 45 | 67 | 63 | 57 |
| Depreciation | 40 | 49 | 54 | 59 | 57 |
| Profit before tax | 136 | 67 | 18 | 40 | 54 |
| 17% | 27% | 32% | 38% | 40% | |
| Current tax | 22 | 11 | 4 | 6 | |
| Deferred tax | 1 | 7 | 2 | 9 | |
| 112 | 49 | 12 | 25 | 83 | |
| YOY Profit Growth % | -56.42% | -75.24% | 106.53% | ||
| EPS in Rs | 16.87 | 7.35 | 1.82 | 3.78 | 12.32 |
| Dividend Payout % | 47% | 138% | 33% |
Compounded Sales Growth
- 3 Years:
- 5%
- TTM:
- 11%
Compounded Profit Growth
- 3 Years:
- -39%
Stock Price CAGR
- 3 Years:
- -4%
- 1 Year:
- 79%
Return on Equity
- 4 Years:
- 5%
- Last Year:
- 3%
Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. EPS restated for bonus issues and splits. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.
Balance Sheet
Consolidated figures in ₹ crore, as at 31 March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 66 | 66 | 66 | 66 |
| Reserves | 922 | 945 | 945 | 960 |
| 810 | 1,057 | 1,162 | 1,060 | |
| Long term borrowings | 169 | 177 | 236 | 207 |
| Short term borrowings | 635 | 870 | 916 | 847 |
| 278 | 244 | 223 | 235 | |
| Trade payables | 171 | 144 | 119 | 128 |
| Current liabilities | 859 | 1,052 | 1,081 | 1,012 |
| Total Liabilities | 2,077 | 2,313 | 2,398 | 2,322 |
| 949 | 1,058 | 1,159 | 1,137 | |
| Gross block | 1,438 | 1,581 | 1,733 | 1,766 |
| Accumulated depreciation | 490 | 523 | 574 | 630 |
| Goodwill & intangibles | 0 | 0 | ||
| CWIP | 39 | 21 | 83 | 6 |
| 1,090 | 1,234 | 1,155 | 1,179 | |
| Inventories | 819 | 1,083 | 1,094 | 1,013 |
| Trade receivables | 154 | 88 | 55 | 64 |
| Cash & equivalents | 104 | 6 | 9 | 9 |
| Current assets | 1,125 | 1,252 | 1,229 | 1,179 |
| Total Assets | 2,077 | 2,313 | 2,398 | 2,322 |
Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.
Cash Flows
Consolidated figures in ₹ crore, financial years ending March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 368 | -101 | 130 | 220 | |
| Profit for the year | 111 | 46 | 15 | 25 |
| Working capital changes | 180 | -227 | -1 | 58 |
| Direct taxes paid | -23 | -18 | -9 | 2 |
| -209 | -166 | -146 | -42 | |
| Fixed assets purchased | -223 | -171 | -146 | -44 |
| Fixed assets sold | 13 | 27 | 1 | 2 |
| Investments purchased | -2 | -24 | -2 | -2 |
| Investments sold | 3 | |||
| -78 | 170 | 19 | -178 | |
| Proceeds from borrowings | 140 | 72 | 132 | 60 |
| Repayment of borrowings | -63 | -78 | -64 | -79 |
| Interest paid | -47 | -46 | -65 | -61 |
| Dividends paid | -23 | -17 | -8 | |
| Net Cash Flow | 81 | -98 | 3 | -0 |
| Free Cash Flow | 145 | -272 | -16 | 176 |
Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.
Ratios
| Ratio | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROE | — | 11.2% | 4.6% | 1.5% | 2.5% |
| ROCE | — | 14.2% | 8.6% | 6.1% | 7.7% |
| Operating margin | — | 7.3% | 5.0% | 4.5% | 3.9% |
| Net margin | — | 4.7% | 2.5% | 0.8% | 1.2% |
| Debt / equity | — | 0.82 | 1.04 | 1.15 | 1.03 |
| Current ratio | — | 1.31 | 1.19 | 1.14 | 1.16 |
| Debtor days | — | 24 | 17 | 11 | 11 |
| Inventory days | — | 156 | 268 | 269 | 215 |
| Days payable | — | 33 | 36 | 29 | 27 |
| Cash conversion cycle | — | 147 | 249 | 251 | 199 |
| Working capital days | — | 41 | 40 | 29 | 29 |
Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.
Shareholding Pattern
Numbers in percentages · as filed with NSE each quarter
- Promoters 50.78%
- FIIs 0.29%
- DIIs 0.82%
- Public 47.09%
| % | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 50.44% | 50.63% | 50.78% | 50.78% | 50.78% | 50.78% | 50.78% | 50.78% | 50.65% | 50.65% | 50.65% | 50.78% |
| 4.83% | 3.42% | 1.95% | 1.26% | 0.83% | 0.66% | 0.54% | 0.43% | 0.35% | 0.45% | 0.54% | 0.29% | |
| Foreign portfolio investors (Cat. I) | 4.83% | 3.42% | 1.95% | 1.26% | 0.83% | 0.66% | 0.50% | 0.39% | 0.31% | 0.44% | 0.54% | 0.29% |
| Foreign portfolio investors (Cat. II) | 0.04% | 0.04% | 0.04% | 0.01% | ||||||||
| 0.45% | 0.45% | 0.45% | 0.45% | 1.36% | 0.45% | 0.45% | 0.45% | 0.45% | 0.79% | 0.79% | 0.82% | |
| Insurance companies | 0.45% | 0.45% | 0.45% | 0.45% | 0.45% | 0.45% | 0.45% | 0.45% | 0.45% | 0.45% | 0.45% | 0.45% |
| Alternative investment funds | 0.90% | 0.34% | 0.34% | 0.37% | ||||||||
| 44.27% | 45.50% | 46.81% | 47.51% | 47.03% | 48.10% | 48.23% | 48.33% | 47.67% | 47.22% | 47.12% | 47.09% | |
| Retail (up to ₹2 lakh) | 16.92% | 18.94% | 18.78% | 18.63% | 17.96% | 18.47% | 19.25% | 19.06% | 18.95% | 18.14% | 16.69% | 16.21% |
| HNIs (above ₹2 lakh) | 20.14% | 20.17% | 20.90% | 21.42% | 21.39% | 21.67% | 21.18% | 21.31% | 20.74% | 20.03% | 20.22% | 20.23% |
| NRIs | 0.82% | 0.76% | 0.79% | 0.91% | 0.92% | 0.93% | 0.86% | 0.97% | 0.92% | 2.24% | 3.31% | 3.42% |
| Bodies corporate | 3.67% | 3.03% | 3.84% | 4.17% | 4.11% | 4.06% | 3.71% | 3.82% | 4.03% | 3.89% | 4.14% | 4.52% |
| IEPF | 0.33% | 0.33% | 0.33% | 0.33% | 0.33% | 0.33% | 0.33% | 0.33% | 0.33% | 0.33% | 0.33% | 0.33% |
| No. of Shareholders | 53,825 | 55,746 | 54,291 | 52,118 | 50,563 | 50,263 | 49,690 | 49,005 | 48,055 | 46,617 | 45,149 | 44,537 |
Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.
Documents
Announcements
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Dhampur Bio Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 201812-Oct-2026
- AppointmentDhampur Bio Organics Limited has informed the Exchange regarding Change in Designation of Mr Pankaj Agarwal as Vice President - Finance and Accounts and Vinamra Agarwal as Vice Pr…01-Oct-2026
- Trading WindowDhampur Bio Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201526-Sep-2026
- General UpdatesDhampur Bio Organics Limited has informed the Exchange about Intimation of Payment of Final Dividend for the Financial Year 2025-2613-Aug-2026
- Resignation of Director/KMP/SMPDhampur Bio Organics Limited has informed the Exchange about Resignation of Director/KMP/SMP31-Jul-2026
- CessationDhampur Bio Organics Limited has informed the Exchange regarding Cessation of Mr. Lalit Dalal as Vice President - Finance and Accounts of the company w.e.f. July 31, 2026.31-Jul-2026
- Shareholders meetingDhampur Bio Organics Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 24, 2026. Further, the company has informed the Exchange r…26-Jul-2026
- Shareholders meetingDhampur Bio Organics Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 24, 202624-Jul-2026
- Copy of Newspaper PublicationDhampur Bio Organics Limited has informed the Exchange about Copy of Newspaper Publication15-Jul-2026
- AppointmentDhampur Bio Organics Limited has informed the Exchange regarding Appointment of M/s. Grant Thornton Bharat LLP as Internal Auditor of the company w.e.f. July 14, 2026 for FY 2026-…14-Jul-2026
- Outcome of Board MeetingDhampur Bio Organics Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.14-Jul-2026
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Dhampur Bio Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 201810-Jul-2026
Annual reports
- Financial Year 202601-JUL-2026
- Financial Year 202518-JUN-2025
- Financial Year 202412-JUN-2024
- Financial Year 2023
Credit ratings
- Credit RatingDhampur Bio Organics Limited has informed the Exchange about Credit Rating05-Sep-2026
- Credit Rating- RevisionDhampur Bio Organics Limited has informed the Exchange about Credit Rating- Revision20-Jan-2026
- Credit Rating- RevisionDhampur Bio Organics Limited has informed the Exchange about Credit Rating- Revision10-Apr-2025
Concalls & investor meets
- Investor PresentationDhampur Bio Organics Limited has informed the Exchange about Investor Presentation15-Jul-2026
- Investor PresentationDhampur Bio Organics Limited has informed the Exchange about Investor Presentation31-May-2026
- Investor PresentationDhampur Bio Organics Limited has informed the Exchange about Investor Presentation22-Jan-2026
- General UpdatesDhampur Bio Organics Limited has informed the Exchange about the Investor Presentation on the performance of the Company for the quarter and half year ended September 30, 2025.13-Nov-2025
- Analysts/Institutional Investor Meet/Con. Call UpdatesDhampur Bio Organics Limited has informed the Exchange about Transcript04-Aug-2025
- Analysts/Institutional Investor Meet/Con. Call UpdatesDhampur Bio Organics Limited has informed the Exchange about Link of Recording29-Jul-2025
- Investor PresentationDhampur Bio Organics Limited has informed the Exchange about Investor Presentation29-Jul-2025
- Investor PresentationDhampur Bio Organics Limited has informed the Exchange about Investor Presentation28-Jul-2025
- Analysts/Institutional Investor Meet/Con. Call UpdatesDhampur Bio Organics Limited has informed the Exchange about Schedule of meet22-Jul-2025
- Analysts/Institutional Investor Meet/Con. Call UpdatesDhampur Bio Organics Limited has informed the Exchange about Transcript09-May-2025
Filings made by the company with NSE; documents open on NSE's website.
Key dates
- Ex-dividend date
- 17 Jul 2026
- Latest quarter
- 30 Jun 2026
- Financial year end
- 31 Mar 2026
Trade with our broking desk
Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.
Latest news
In the news
From the company (NSE)
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Dhampur Bio Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018NSE filing · 12-Oct-2026
- AppointmentDhampur Bio Organics Limited has informed the Exchange regarding Change in Designation of Mr Pankaj Agarwal as Vice President - Finance and Accounts and Vinamra Agarwal as Vice Pr…NSE filing · 01-Oct-2026
- Trading WindowDhampur Bio Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015NSE filing · 26-Sep-2026
- General UpdatesDhampur Bio Organics Limited has informed the Exchange about Intimation of Payment of Final Dividend for the Financial Year 2025-26NSE filing · 13-Aug-2026
- Resignation of Director/KMP/SMPDhampur Bio Organics Limited has informed the Exchange about Resignation of Director/KMP/SMPNSE filing · 31-Jul-2026
- CessationDhampur Bio Organics Limited has informed the Exchange regarding Cessation of Mr. Lalit Dalal as Vice President - Finance and Accounts of the company w.e.f. July 31, 2026.NSE filing · 31-Jul-2026
- Shareholders meetingDhampur Bio Organics Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 24, 2026. Further, the company has informed the Exchange r…NSE filing · 26-Jul-2026
- Shareholders meetingDhampur Bio Organics Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 24, 2026NSE filing · 24-Jul-2026
Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.
Questions about Dhampur Bio Organics Limited
What is the share price of Dhampur Bio Organics Limited today?
Dhampur Bio Organics Limited (DBOL) last traded at ₹140.73 on NSE (16 Oct 2026, 3:29 PM IST). Prices may be delayed.
What is the market cap of Dhampur Bio Organics Limited?
About ₹926 crore at the latest price.
What is the P/E ratio of Dhampur Bio Organics Limited?
About 28.0 times its earnings over the last 12 months.
Is Dhampur Bio Organics Limited a good investment?
We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.
How can I buy Dhampur Bio Organics Limited shares?
You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.
Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).
Talk to us
Have a question about this topic?
Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.
Experts are available Mon–Sat, 10 AM – 7 PM
Book your free wealth consultation
- 100% free
- No obligation
- Reply within 2 hours
Request received!
Thank you for trusting Plenitude Connect. An expert will contact you shortly. Please check your inbox for details.